Investors
News
Contact

About us
Inhalers
- Inhalers
- ICOres
- ICOcap
- ICOpre
- ICOone
- ICOone Nasal
- Patents
Development services
Partner with us
- Partner with us
- Access our inhalers
Insights
- Replacing injections with inhalation
- Boost your business with an innovative inhaler partner
Investors
Search
Menu Menu

Iconovo – Intervju Erik Penser Bank 17 februari 2021 (only in Swedish)

February 18, 2021/in News, Presentations /by Eva Norell

Iconovos VD Johan Wäborg intervjuas av aktieanalytiker Johan Löchen från Erik Penser Bank. Se videon youtu.be.

Kontakter

Johan Wäborg, VD
+46 707 78 51 71
johan.waborg@iconovo.se

Share this entry

Share on Twitter
Share on LinkedIn
Share by Mail

https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png 0 0 Eva Norell https://www.iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png Eva Norell2021-02-18 08:42:422021-02-18 08:42:42Iconovo – Intervju Erik Penser Bank 17 februari 2021 (only in Swedish)

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B

POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 70 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

Home
Development services
Investors

Press releases

VD Johan Wäborg förvärvar aktier för 1 100 000 SEK (only in Swedish) Abbreviated interim report january – december 2020

Scroll to top